Precision medicine for cancer with next-generation functional diagnostics.

Nat Rev Cancer 2015 Dec 5;15(12):747-56. Epub 2015 Nov 5.

Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, USA.

Precision medicine is about matching the right drugs to the right patients. Although this approach is technology agnostic, in cancer there is a tendency to make precision medicine synonymous with genomics. However, genome-based cancer therapeutic matching is limited by incomplete biological understanding of the relationship between phenotype and cancer genotype. This limitation can be addressed by functional testing of live patient tumour cells exposed to potential therapies. Recently, several 'next-generation' functional diagnostic technologies have been reported, including novel methods for tumour manipulation, molecularly precise assays of tumour responses and device-based in situ approaches; these address the limitations of the older generation of chemosensitivity tests. The promise of these new technologies suggests a future diagnostic strategy that integrates functional testing with next-generation sequencing and immunoprofiling to precisely match combination therapies to individual cancer patients.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc4015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970460PMC
December 2015
13 Reads

Publication Analysis

Top Keywords

precision medicine
12
functional testing
8
cancer
5
novel methods
4
methods tumour
4
tumour manipulation
4
including novel
4
reported including
4
manipulation molecularly
4
precise assays
4
responses device-based
4
tumour responses
4
assays tumour
4
technologies reported
4
molecularly precise
4
'next-generation' functional
4
live patient
4
patient tumour
4
testing live
4
addressed functional
4

Similar Publications